# First National Corp: financial statements, quarterly

FXNC · Nasdaq · CIK 719402 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/fxnc.md) · [Financials](/companies/fxnc/financials.md) · [Filings](/companies/fxnc/filings.md) · [Insiders](/companies/fxnc/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/fxnc/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $k | [2,855](/filings/0001437749-24-035225.md) | [2,146 d](/filings/0001437749-25-010228.md) | [2,540](/filings/0001437749-25-016792.md) | [2,510](/filings/0001437749-25-026434.md) | [2,653](/filings/0001437749-25-035092.md) | [6,852 d](/filings/0001437749-26-009748.md) | [3,275](/filings/0001437749-26-016708.md) | [3,428](/filings/0001437749-26-027538.md) | [4,108](/filings/0001437749-25-035092.md) | [3,479 d](/filings/0001437749-26-009748.md) | [3,284](/filings/0001437749-26-016708.md) | [3,418](/filings/0001437749-26-027538.md) |
| Interest expense | $k | [3,948](/filings/0001437749-23-031533.md) | [4,465 d](/filings/0001437749-24-010057.md) | [5,484](/filings/0001437749-24-016599.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $k | [731](/filings/0001437749-24-035225.md) | [(321) d](/filings/0001437749-25-010228.md) | [801](/filings/0001437749-25-016792.md) | [679](/filings/0001437749-25-026434.md) | [545](/filings/0001437749-25-035092.md) | [(943) d](/filings/0001437749-26-009748.md) | [297](/filings/0001437749-26-016708.md) | [1,284](/filings/0001437749-26-027538.md) | [1,270](/filings/0001437749-25-035092.md) | [1,390 d](/filings/0001437749-26-009748.md) | [1,181](/filings/0001437749-26-016708.md) | [1,393](/filings/0001437749-26-027538.md) |
| Net income | $k | [3,121](/filings/0001437749-24-035225.md) | [(851) d](/filings/0001437749-25-010228.md) | [3,209](/filings/0001437749-25-016792.md) | [2,442](/filings/0001437749-25-026434.md) | [2,248](/filings/0001437749-25-035092.md) | [(933) d](/filings/0001437749-26-009748.md) | [1,598](/filings/0001437749-26-016708.md) | [5,051](/filings/0001437749-26-027538.md) | [5,550](/filings/0001437749-25-035092.md) | [5,504 d](/filings/0001437749-26-009748.md) | [4,887](/filings/0001437749-26-016708.md) | [5,743](/filings/0001437749-26-027538.md) |
| Diluted EPS | $ per share | [0.50](/filings/0001437749-24-035225.md) | not reported | [0.51](/filings/0001437749-25-016792.md) | [0.39](/filings/0001437749-25-026434.md) | [0.36](/filings/0001437749-25-035092.md) | not reported | [0.18](/filings/0001437749-26-016708.md) | [0.56](/filings/0001437749-26-027538.md) | [0.62](/filings/0001437749-25-035092.md) | not reported | [0.54](/filings/0001437749-26-016708.md) | [0.63](/filings/0001437749-26-027538.md) |
| Basic EPS | $ per share | [0.50](/filings/0001437749-24-035225.md) | not reported | [0.51](/filings/0001437749-25-016792.md) | [0.39](/filings/0001437749-25-026434.md) | [0.36](/filings/0001437749-25-035092.md) | not reported | [0.18](/filings/0001437749-26-016708.md) | [0.56](/filings/0001437749-26-027538.md) | [0.62](/filings/0001437749-25-035092.md) | not reported | [0.54](/filings/0001437749-26-016708.md) | [0.64](/filings/0001437749-26-027538.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | [87.2](/filings/0001437749-25-010228.md) | not reported | [136](/filings/0001437749-24-026727.md) | [127](/filings/0001437749-24-035225.md) | [163](/filings/0001437749-26-009748.md) | [206](/filings/0001437749-25-016792.md) | [194](/filings/0001437749-25-026434.md) | [189](/filings/0001437749-25-035092.md) | [161](/filings/0001437749-26-027538.md) | [188](/filings/0001437749-26-016708.md) | [166](/filings/0001437749-26-027538.md) |
| Total assets | $m | [1,366](/filings/0001437749-23-031533.md) | [1,419](/filings/0001437749-25-010228.md) | [1,447](/filings/0001437749-24-016599.md) | [1,458](/filings/0001437749-24-026727.md) | [1,451](/filings/0001437749-24-035225.md) | [2,010](/filings/0001437749-26-009748.md) | [2,033](/filings/0001437749-25-016792.md) | [2,041](/filings/0001437749-25-026434.md) | [2,031](/filings/0001437749-25-035092.md) | [2,038](/filings/0001437749-26-027538.md) | [2,076](/filings/0001437749-26-016708.md) | [2,076](/filings/0001437749-26-027538.md) |
| Total liabilities | $m | [1,254](/filings/0001437749-23-031533.md) | [1,303](/filings/0001437749-25-010228.md) | [1,329](/filings/0001437749-24-016599.md) | [1,338](/filings/0001437749-24-026727.md) | [1,326](/filings/0001437749-24-035225.md) | [1,844](/filings/0001437749-26-009748.md) | [1,865](/filings/0001437749-25-016792.md) | [1,868](/filings/0001437749-25-026434.md) | [1,850](/filings/0001437749-25-035092.md) | [1,852](/filings/0001437749-26-027538.md) | [1,887](/filings/0001437749-26-016708.md) | [1,882](/filings/0001437749-26-027538.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [112](/filings/0001437749-24-035225.md) | [116](/filings/0001437749-26-009748.md) | [118](/filings/0001437749-25-026434.md) | [120](/filings/0001437749-25-035092.md) | [125](/filings/0001437749-25-035092.md) | [167](/filings/0001437749-26-027538.md) | [169](/filings/0001437749-26-027538.md) | [174](/filings/0001437749-26-027538.md) | [181](/filings/0001437749-25-035092.md) | [186](/filings/0001437749-26-027538.md) | [189](/filings/0001437749-26-027538.md) | [194](/filings/0001437749-26-027538.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [3.4 d](/filings/0001437749-24-035225.md) | [5.1 d](/filings/0001437749-25-010228.md) | [4.7](/filings/0001437749-25-016792.md) | [3.6 d](/filings/0001437749-25-026434.md) | [6.1 d](/filings/0001437749-25-035092.md) | [(36.7) d](/filings/0001437749-26-009748.md) | [3.5](/filings/0001437749-26-016708.md) | [4.7 d](/filings/0001437749-26-027538.md) | [8.4 d](/filings/0001437749-25-035092.md) | [8.4 d](/filings/0001437749-26-009748.md) | [6.4](/filings/0001437749-26-016708.md) | [6.9 d](/filings/0001437749-26-027538.md) |
| Capital expenditure | $m | [0.2 d](/filings/0001437749-24-035225.md) | [1.2 d](/filings/0001437749-25-010228.md) | [0.3](/filings/0001437749-25-016792.md) | [0.7 d](/filings/0001437749-25-026434.md) | [1.2 d](/filings/0001437749-25-035092.md) | [1.1 d](/filings/0001437749-26-009748.md) | [0.5](/filings/0001437749-26-016708.md) | [0.6 d](/filings/0001437749-26-027538.md) | [1.6 d](/filings/0001437749-25-035092.md) | [1.5 d](/filings/0001437749-26-009748.md) | [0.5](/filings/0001437749-26-016708.md) | [0.4 d](/filings/0001437749-26-027538.md) |
| Dividends paid | $m | [0.9 d](/filings/0001437749-24-035225.md) | [0.9 d](/filings/0001437749-25-010228.md) | [0.9](/filings/0001437749-25-016792.md) | [0.9 d](/filings/0001437749-25-026434.md) | [0.9 d](/filings/0001437749-25-035092.md) | [1.3 d](/filings/0001437749-26-009748.md) | [1.3](/filings/0001437749-26-016708.md) | [1.3 d](/filings/0001437749-26-027538.md) | [1.3 d](/filings/0001437749-25-035092.md) | [1.5 d](/filings/0001437749-26-009748.md) | [1.5](/filings/0001437749-26-016708.md) | [1.5 d](/filings/0001437749-26-027538.md) |
| Share repurchases | $m | [0.1 d](/filings/0001437749-23-031533.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | thousands of shares | [6,264](/filings/0001437749-23-031533.md) | [6,281](/filings/0001437749-24-016599.md) | [6,277](/filings/0001437749-24-026727.md) | [6,271](/filings/0001437749-24-035225.md) | [6,283](/filings/0001437749-25-016792.md) | [6,289](/filings/0001437749-25-026434.md) | [6,303](/filings/0001437749-25-035092.md) | [9,006](/filings/0001437749-26-016708.md) | [9,002](/filings/0001437749-26-027538.md) | [9,023](/filings/0001437749-25-035092.md) | [9,047](/filings/0001437749-26-016708.md) | [9,068](/filings/0001437749-26-027538.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 9,042,629 at 2026-08-07, from the cover of the [10-Q filed 2026-08-13](/filings/0001437749-26-027538.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:22 ET. No prices; not investment advice.